Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antivinculin Antibodies in Systemic Sclerosis: Associations With Slow Gastric Transit and Extraintestinal Clinical Phenotype.

Arthritis care & research - 1 Oct 2023

Herrán María, Adler Brittany L, Perin Jamie, Morales Walter, Pimentel Mark, McMahan Zsuzsanna H

Abstract excerpt

OBJECTIVE: The gastrointestinal (GI) tract is commonly affected in systemic sclerosis (SSc). A positive association between antivinculin antibody levels and GI symptom severity is reported in SSc. We sought to examine whether antivinculin antibodies associate with measures of GI dysmotility and extraintestinal clinical phenotype in SSc. METHODS: A total of 88 well-characterized patients with SSc and GI disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Enzyme-Linked Immunosorbent Assay

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gastrointestinal Diseases

Share to Phenotype

Share to Scleroderma, Systemic

Source

Open in PubMed Open full text

Identifiers

PMID: 36951252
DOI: 10.1002/acr.25118
PMCID: PMC10517080

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antivinculin Antibodies in Systemic Sclerosis: Associations With Slow Gastric Transit and Extraintestinal Clinical Phenotype.PMID 36951252Read ↗

Objective gastrointestinal involvement in patients with systemic sclerosis: Prevalence and clinico-immunological phenotypes in the REMSCLE registry.Semantic proximity Read ↗

Novel autoantibodies in patients with systemic sclerosis and gastrointestinal dysfunction provide insight into disease pathogenesisSemantic proximity Read ↗

Anti-muscarinic 3 antibodies associate with a severe clinical phenotype in patients with systemic sclerosis.Semantic proximity Read ↗

Anti-Gephyrin antibodies: A novel specificity in patients with systemic sclerosis and lower bowel dysfunctionSemantic proximity Read ↗

Determining the Risk Factors and Clinical Features Associated With Severe Gastrointestinal Dysmotility in Systemic Sclerosis.Semantic proximity Read ↗

Evaluating the Associations Among Dysautonomia, Gastrointestinal Transit, and Clinical Phenotype in Patients With Systemic Sclerosis.Semantic proximity Read ↗

Proteome-wide serology reveals immune-defined subtypes of gastrointestinal disease in systemic sclerosisSemantic proximity Read ↗

Characteristics of Japanese patients with systemic sclerosis with dysphagia: a single-center studySemantic proximity Read ↗

Serum markers of microbial translocation and intestinal damage in assessment of gastrointestinal tract involvement in systemic sclerosisSemantic proximity Read ↗

Oesophageal dysmotility patterns are associated with distinct clinical phenotypes and prognosis in patients with systemic sclerosis.Semantic proximity Read ↗

The Gut-Heart Axis in Systemic Sclerosis: Evidence from the GENISOS cohortSemantic proximity Read ↗

Distinct clinical trajectories of gastrointestinal progression among patients with systemic sclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.